Trends in PSA, age and prostate cancer detection among black and white men from 1990-2006 at a tertiary care center

Cancer

Volumn 116, Issue 16, 2010, Pages 3910-3915

  Potts, Jeannette M ^a   Lutz, Megan ^b   Walker, Esteban ^c   Modlin, Charles ^c   Klein, Eric ^c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Biopsy; Prostate cancer; Prostate specific antigen (PSA); Race; Screening

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTRONIC MEDICAL RECORD; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; AFRICAN AMERICAN; AGE; CAUCASIAN; EARLY DIAGNOSIS; ETHNOLOGY; EVALUATION STUDY; METABOLISM; MIDDLE AGED; PROSTATIC NEOPLASMS; TIME;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; TIME FACTORS;

PROSTATE SPECIFIC ANTIGEN;

EID: 77956854150     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25124     Document Type: Article

References (16)

1. Powell IJ. Epidemiology and pathophysiology of prostate cancer in African-American men. J Urol. 2007;177:444-449.
2. Jones BA, Liu WL, Araujo AB, et al. Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev. 2008;17:2825-2834.
3. Northern Ohio Data & Information Service (NODIS), Maxine Goodman Levin College of Urban Affairs, Cleveland State University. Available at http://nodis.csuohio.edu Accessed April 29, 2010.
4. Smith DS, Carvalhal GF, Mager DE, Bullock AD, Catalona WJ. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men. J Urol. 1998;160:1734-1738. (Pubitemid 128746747)
5. Saraiya M, Kottiri BJ, Leadbetter S, et al. Total and percent free prostate-specific antigen levels among US men, 2001-2002. Cancer Epidemiol Biomarkers Prev. 2005;14:2178-2182.
6. Moul JW. Population screening for prostate cancer and emerging concepts for young men. Clin Prostate Cancer. 2003;2:87-89.
7. Welch HG, Schwartz LM, Woloshin S. Prostate-specific antigen levels in the United States: implications of various definitions for abnormal. J Natl Cancer Inst. 2005;97:1132-1137. (Pubitemid 41511212)
8. Ross LE, Berkowitz Z, Ekwueme DU. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey. CEBP. 2008;17:636-644.
9. Stephenson RA, Smart CR, Mineau GP, James BC, Janerich DT, Dibble RL. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence-data from the Utah Cancer Registry. Cancer. 1997;79:188-190.
10. Porter CR, Latchamsetty KC, Coogan CL, Kim J. Absence of lower urinary tract symptoms is an independent predictor for cancer at prostate biopsy, but prostate-specific antigen is not: results from a prospective series of 569 patients. Clin Prostate Cancer. 2005;4:50-54.
11. Porter CR, Kim J. Low AUA symptom score independently predicts positive prostate needle biopsy: results from a racially diverse series of 411 patients. Urology. 2004;63:90-94. (Pubitemid 38147557)
12. Latchamsetty KC, Kim J, Porter CR. Prostate specific antigen remains an independent predictor of cancer at prostate biopsy in black American men but not in white men: results from a consecutive series of 914 men. J Urol. 2006;175(3 pt 1):913-917. (Pubitemid 43200016)
13. Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med. 2009;360:11320.
14. Egevad L. Recent trends in Gleason grading of prostate cancer. II. Prognosis, reproducibility and reporting. Anal Quant Cytol Histol. 2008;30:254-260.
15. Kuroiwa K, Uchino H, Yokomizo A, Naito S. Impact of reporting rules of biopsy Gleason score for prostate cancer. J Clin Pathol. 2009;62:260-263.
16. Egevad L, Allsbrook WC, Epstein JI. Current practice of diagnosis and reporting of PIN and glandular atypia among genitourinary pathologists. Mod Pathol. 2006;19:180-185.